Somatostatin receptor scintigraphy in the management of cerebral malignant ectomesenchymoma: a case report

M Papós; A Pekrun; J W Herms; T M Behr; J Meller; H H Rustenbeck; H A Kretzschmar; W Becker

doi:10.1007/s002470000404

Somatostatin receptor scintigraphy in the management of cerebral malignant ectomesenchymoma: a case report

Pediatr Radiol. 2001 Mar;31(3):169-72. doi: 10.1007/s002470000404.

Authors

M Papós¹, A Pekrun, J W Herms, T M Behr, J Meller, H H Rustenbeck, H A Kretzschmar, W Becker

Affiliation

¹ Department of Nuclear Medicine, Georg August University, Göttingen, Germany. paposm@comser.szot.u-szeged.hu

PMID: 11297080
DOI: 10.1007/s002470000404

Abstract

A 10-year-old girl presented with a cerebral malignant ectomesenchymoma (MEM), a very unusual tumour with undifferentiated mesenchymal as well as ectodermal elements. Somatostatin receptor scintigraphy (SRS) was performed during the diagnostic workup. The recurrent residual tumour mass was exactly visualized with SRS, and was negative after successful treatment of the patient. The potential application of SRS in initial staging, follow-up and therapy planning in MEM is discussed. This is the first application of SRS in MEM.

Publication types

Case Reports
Research Support, Non-U.S. Gov't

MeSH terms

Brain Neoplasms / diagnostic imaging*
Brain Neoplasms / surgery
Child
Female
Follow-Up Studies
Humans
Mesenchymoma / diagnostic imaging*
Mesenchymoma / surgery
Neoplasm Recurrence, Local / diagnostic imaging*
Neoplasm Recurrence, Local / surgery
Neoplasm, Residual / diagnostic imaging*
Neoplasm, Residual / surgery
Parietal Lobe / diagnostic imaging
Parietal Lobe / surgery
Receptors, Somatostatin / analysis*
Reoperation
Somatostatin / analogs & derivatives*
Temporal Lobe / diagnostic imaging
Temporal Lobe / surgery
Tomography, Emission-Computed, Single-Photon*

Substances

Receptors, Somatostatin
Somatostatin
pentetreotide